In connection with the implementation of the project entitled “Development and introduction to the market of the first non-antibiotic product for the treatment of infectious eye diseases with an innovative ophthalmological composition in the form of eye drops, containing an active substance – povidone iodine” funded by the state budget from the Medical Research Agency, Zakłady Farmaceutyczne Polpharma S.A., are requesting bids to conduct a non-clinical study of pharmacodynamics and safety after repeated administration in an animal model of adenoviral eye infection (adaptive design).
Details of the price inquiry can be found in the documents attached below.